A detailed history of Rockefeller Capital Management L.P. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 76,038 shares of NTLA stock, worth $926,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,038
Previous 100,914 24.65%
Holding current value
$926,142
Previous $2.26 Million 30.82%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.72 - $27.36 $490,554 - $680,607
-24,876 Reduced 24.65%
76,038 $1.56 Million
Q2 2024

Aug 12, 2024

BUY
$20.02 - $27.22 $491,871 - $668,768
24,569 Added 32.18%
100,914 $2.26 Million
Q1 2024

May 14, 2024

BUY
$23.82 - $32.8 $473,208 - $651,604
19,866 Added 35.17%
76,345 $2.1 Million
Q4 2023

Feb 14, 2024

BUY
$23.16 - $32.34 $230,858 - $322,365
9,968 Added 21.43%
56,479 $1.72 Million
Q3 2023

Nov 14, 2023

BUY
$31.62 - $45.78 $305,385 - $442,143
9,658 Added 26.21%
46,511 $1.47 Million
Q2 2023

Aug 14, 2023

BUY
$34.58 - $46.03 $162,664 - $216,525
4,704 Added 14.63%
36,853 $1.5 Million
Q1 2023

May 17, 2023

BUY
$33.3 - $44.82 $292,640 - $393,878
8,788 Added 37.62%
32,149 $1.2 Million
Q4 2022

Mar 06, 2023

SELL
$33.21 - $62.69 $236,754 - $446,917
-7,129 Reduced 23.38%
23,361 $815,000
Q3 2022

Nov 02, 2022

BUY
$53.92 - $71.7 $429,095 - $570,588
7,958 Added 35.32%
30,490 $1.71 Million
Q2 2022

Aug 12, 2022

BUY
$38.49 - $76.21 $24,710 - $48,926
642 Added 2.93%
22,532 $1.17 Million
Q1 2022

May 13, 2022

BUY
$58.27 - $118.99 $397,051 - $810,797
6,814 Added 45.2%
21,890 $1.59 Million
Q4 2021

Feb 14, 2022

BUY
$100.76 - $138.36 $1.18 Million - $1.61 Million
11,669 Added 342.5%
15,076 $1.78 Million
Q3 2021

Nov 12, 2021

BUY
$132.37 - $176.78 $360,972 - $482,079
2,727 Added 401.03%
3,407 $457,000
Q2 2021

Aug 10, 2021

BUY
$60.88 - $161.91 $3,287 - $8,743
54 Added 8.63%
680 $109,000
Q1 2021

May 11, 2021

BUY
$46.59 - $83.68 $11,787 - $21,171
253 Added 67.83%
626 $50,000
Q4 2020

Feb 12, 2021

BUY
$18.83 - $63.53 $903 - $3,049
48 Added 14.77%
373 $20,000
Q3 2020

Nov 13, 2020

BUY
$17.47 - $24.93 $5,677 - $8,102
325 New
325 $6,000
Q1 2020

May 12, 2020

SELL
$9.44 - $15.58 $66 - $109
-7 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$10.43 - $17.67 $73 - $123
7 New
7 $0

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $926M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.